Jul 28, 2016, 15:46 PM by Michael Croft

GAITHERSBURG, MD - Jul 28, 2016 - The National Institute of Standards and Technology (NIST) has issued one of the world’s most intricate measurement standards: an exhaustively analyzed antibody protein that the biopharmaceutical industry will use to help ensure the quality of treatments across a widening range of health conditions, including cancers, autoimmune disorders and infectious diseases

Jul 28, 2016, 15:03 PM by Michael Croft

Forbes | BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.

Jul 28, 2016, 12:25 PM by Michael Croft

MIT Technology Review | Startups focused on Asia are among those aiming to bring precision medicine to far more people.

Jul 28, 2016, 10:32 AM by Michael Croft

Computerworld | Microsoft is creating some 3.2 million square feet of data center space in the West Des Moines, Iowa, area but in three separate locations. The combined investment is about $3.5 billion.

Jul 27, 2016, 23:32 PM by Michael Croft

SHIRLEY, NY - Jul 28, 2016 - Creative Biostructure is a provider of membrane protein products and services. At here, we provide a variety of technologies to meet the requirements of each customer

Jul 27, 2016, 10:11 AM by Michael Croft

Xconomy | After eight years at the helm of Eli Lilly, a tenure characterized by a steadfast belief in home-grown research, rather than deals, John Lechleiter is retiring. David Ricks, who currently runs Lilly's diversified bio-medicines unit-which develops drugs for neurological and cardiovascular disorders, among other diseases-will be named CEO on Jan. 1

Jul 27, 2016, 10:10 AM by Michael Croft

Nature News & Comment | Nature and the Nature journals are diversifying their presentation of performance indicators. Impact factor is crude and also misleading. It effectively undervalues papers in disciplines that are slow-burning or have lower characteristic citation rates. Accordingly, Nature has updated its online journal metrics page to include an array of additional bibliometric data.

Jul 27, 2016, 05:40 AM by Michael Croft

ALBANY, NY - Jul 27, 2016 - Bioelectronics is an emerging branch of medical science dealing with combined application of the principles of biology and electrical engineering

Jul 26, 2016, 10:34 AM by Michael Croft

MUNICH, GERMANY - Jul 26, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of the Tissue Studio 4

Jul 26, 2016, 09:10 AM by Michael Croft

Computerworld | Nvidia keeps upping the performance with each new GPU based on the Pascal architecture. Its latest, the Quadro P6000, can deliver 12 teraflops of single-precision performance, a teraflop more than the Titan X unveiled just last week.

Jul 26, 2016, 06:59 AM by Michael Croft

SLOVAKIA, SLOVAKIA - Jul 26, 2016 - Slovakia-based contract development and manufacturing organisation (CDMO) Saneca Pharma has sold registration dossiers for more than 20 pharmaceutical products to Switzerland-headquartered Xantis Pharma as part of an exclusive agreement

Jul 25, 2016, 16:49 PM by Michael Croft

MIT Technology Review | His startup is using data to unlock the connections between DNA and illness.

Jul 25, 2016, 03:14 AM by Michael Croft

BASEL, SWITZERLAND - Jul 25, 2016 -  BC Platforms, a world leader in genomic data management solutions today announces that it has signed a partnership with Codigo46, an emerging Mexican company, focused on building and managing the largest biobank in Latin-America in co-operation with Mexican health and research specialists to deliver clinical patient benefits and future personalised medicines through academic and commercial research

Jul 22, 2016, 10:38 AM by Michael Croft

Nature News & Comment | Gene-editing technique to treat lung cancer is due to be tested in people in August. Sichuan University's West China Hospital in Chengdu plans to inject lung cancer patients with cells modified using the CRISPR-Cas9 gene-editing technique. The clinical trial received ethical approval from the hospital July 6.

Jul 21, 2016, 12:37 PM by Michael Croft

PRINCETON, NJ - Jul 21, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the appointment of Nathan Teuscher, PhD, to vice president of pharmacometric solutions

Jul 20, 2016, 14:35 PM by Michael Croft

Bio-IT World | Bioz, Inc. came out of stealth today with the introduction of a search engine for life science experimentation. The company, started by Stanford research scientist Karin Lachmi and serial entrepreneur Daniel Levitt, also announced $3 million in seed funding, led by 5AM Ventures.

Jul 20, 2016, 08:07 AM by Michael Croft

PRINCETON, NJ - Jul 20, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp® Population-based Simulator

Jul 20, 2016, 04:55 AM by Michael Croft

Bio-IT World It's been a busy two years for Seven Bridges. In May 2014, Seven Bridges was introducing its open source cancer informatics pipeline: open source algorithms running on the proprietary Seven Bridges cloud infrastructure. Less than six months later, the company was awarded one of three National Cancer Institute Cloud Pilot contracts.

Jul 19, 2016, 10:02 AM by Michael Croft

MUNICH, GERMANY - Jul 19, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization and Indivumed, GmbH, based in Hamburg, Germany announced today a strategic partnership to offer a unique combination of tissue-based biomarker validation and assay development with Definiens Cognition Network Technology® for image analysis and data mining

Jul 19, 2016, 09:20 AM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Jul 19, 2016 - NewLeaf Symbiotics, announced today the appointment of Dr. Janne Kerovuo as Vice President for Research and Discovery